XPAT

What this means for you

Registered since 01 Dec 2020. The owner can stop confusingly similar uses in the classes it covers.

Record

Serial number

88431972

Registration number

6212039

Mark type

Stylized text

Filed

15 May 2019

Published for opposition

21 Jan 2020

Registered

01 Dec 2020

Attorney of record

Aaron D. Hendelman

Goods and services

• Class 001 — Chemicals: Chemicals used in the manufacture of pharmaceuticals; reagents, enzymes, and nucleotides for scientific or medical research; protein polymeric intermediates for use in the manufacture of pharmaceutical preparations; biomedical compounds, namely, peptides, peptidomimetics, and protein polymeric intermediates used in the manufacture of pharmaceutical preparations
• Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of cancerous and viral diseases; pharmaceutical preparations for use in the field of oncology; medical diagnostic reagents; reagents for use in testing proteins for medical and diagnostic purposes

Owner

• Amunix Pharmaceuticals, Inc., South San Francisco, CA, US
• Amunix Pharmaceuticals, Inc., South San Francisco, CA, US
• Amunix Pharmaceuticals, Inc., Mountain View, CA, US

Prosecution history

• 01 Dec 2025 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
• 01 Dec 2020 — REGISTERED-PRINCIPAL REGISTER
• 27 Oct 2020 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
• 26 Oct 2020 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
• 02 Oct 2020 — STATEMENT OF USE PROCESSING COMPLETE
• 29 Sept 2020 — USE AMENDMENT FILED
• 29 Sept 2020 — TEAS STATEMENT OF USE RECEIVED
• 24 Sept 2020 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
• 23 Sept 2020 — SOU EXTENSION 1 GRANTED
• 15 Sept 2020 — SOU EXTENSION 1 FILED
• 22 Sept 2020 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
• 15 Sept 2020 — SOU TEAS EXTENSION RECEIVED
• 17 Mar 2020 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
• 21 Jan 2020 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
• 21 Jan 2020 — PUBLISHED FOR OPPOSITION